Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions-Reference-Cited by-同舟云学术

Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions

Published:2014-12 Issue:2 Volume:23 Page:442-446
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Bichuetti-Silva Danielli C.^ORCID,Furlan Fernanda P.,Nobre Fernanda A.,Pereira Camila T.M.,Gonçalves Tessa R.T.,Gouveia-Pereira Mariana,Rota Rafael,Tavares Lusinete,Mazzucchelli Juliana T.L.,Costa-Carvalho Beatriz T.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference44 articles.

1. Intravenous immunoglobulin in immunodeficiencies: more than mere replacement therapy;Kaveri;Clin Exp Immunol,2011

2. Use of intravenous immunoglobulin G (IVIG);Looney;Best Pract Res Clin Haematol,2006

3. Intravenous immunoglobulin consensus statement;Sacher;J Allergy Clin Immunol,2001

4. Intravenous immunoglobulins: clinical experience and viral safety;Ballow;J Am Pharm Assoc,2002

5. Risks and benefits of intravenous immunoglobulin treatment in children;Fasano;Curr Opin Pediatr,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease;BMC Pediatrics;2024-01-20

2. A review of the adverse effects of intravenous immunoglobulin infusion in pediatric multisystem inflammatory disease patients (MIS-C);2023-12-14

3. The use of intravenous immunoglobulin in the treatment of Hashimoto’s encephalopathy: case based review;Frontiers in Neurology;2023-09-07

4. Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study;Drug Safety;2023-06-28

5. Investigation of cardiac adverse effects in COVID-19 ARDS patients treated with intravenous immunoglobulin;Northern Clinics of Istanbul;2023